Nationwide incidence and treatment pattern of retinopathy of prematurity in South Korea using the 2007-2018 national health insurance claims data
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Hong, Eun Hee | - |
dc.contributor.author | Shin, Yong Un | - |
dc.contributor.author | Bae, Gi Hwan | - |
dc.contributor.author | Choi, Young Jin | - |
dc.contributor.author | Ahn, Seong Joon | - |
dc.contributor.author | Sobrin, Lucia | - |
dc.contributor.author | Hong, Rimkyung | - |
dc.contributor.author | Kim, Inah | - |
dc.contributor.author | Cho, Heeyoon | - |
dc.date.accessioned | 2022-07-06T11:12:57Z | - |
dc.date.available | 2022-07-06T11:12:57Z | - |
dc.date.created | 2021-05-13 | - |
dc.date.issued | 2021-12 | - |
dc.identifier.issn | 2045-2322 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/hanyang/handle/2021.sw.hanyang/140290 | - |
dc.description.abstract | The aim of this study is to investigate the nationwide incidence and treatment pattern of retinopathy of prematurity (ROP) in South Korea. Using the population-based National Health Insurance database (2007–2018), the nationwide incidence of ROP among premature infants with a gestational age (GA) < 37 weeks (GA < 28 weeks, GA28; 28 weeks ≤ GA < 37 weeks; GA28-37) and the percentage of ROP infants who underwent treatment [surgery (vitrectomy, encircling/buckling); retinal ablation (laser photocoagulation, cryotherapy)] were evaluated. We identified 141,964 premature infants, 42,300 of whom had ROP, with a nationwide incidence of 29.8%. The incidence of ROP in GA28 group was 4.3 times higher than in GA28-37 group (63.6% [2240/3522] vs 28.9% [40,060/138,442], p < 0.001). As for the 12-year trends, the incidence of ROP decreased from 39.5% (3308/8366) in 2007 to 23.5% (2943/12,539) in 2018. 3.0% of ROP infants underwent treatment (25.0% in GA28; 1.7% in GA28-37); 0.2% (84/42,300) and 2.9% (1214/42,300) underwent surgery and retinal ablation, respectively. The overall percentage of ROP infants who underwent treatment has decreased from 4.7% in 2007 to 1.8% in 2018. This first Korean nationwide epidemiological study of ROP revealed a decreased incidence of ROP and a decreased percentage of ROP infants undergoing conventional treatment during a 12-year period. | - |
dc.language | 영어 | - |
dc.language.iso | en | - |
dc.publisher | Nature Research | - |
dc.title | Nationwide incidence and treatment pattern of retinopathy of prematurity in South Korea using the 2007-2018 national health insurance claims data | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Shin, Yong Un | - |
dc.contributor.affiliatedAuthor | Kim, Inah | - |
dc.identifier.doi | 10.1038/s41598-021-80989-z | - |
dc.identifier.scopusid | 2-s2.0-85099479341 | - |
dc.identifier.wosid | 000626775600051 | - |
dc.identifier.bibliographicCitation | Scientific Reports, v.11, no.1, pp.1 - 10 | - |
dc.relation.isPartOf | Scientific Reports | - |
dc.citation.title | Scientific Reports | - |
dc.citation.volume | 11 | - |
dc.citation.number | 1 | - |
dc.citation.startPage | 1 | - |
dc.citation.endPage | 10 | - |
dc.type.rims | ART | - |
dc.type.docType | Article | - |
dc.description.journalClass | 1 | - |
dc.description.isOpenAccess | Y | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Science & Technology - Other Topics | - |
dc.subject.keywordPlus | DEVELOPING RETINAL-DETACHMENT | - |
dc.subject.keywordPlus | INTRAVITREAL BEVACIZUMAB | - |
dc.subject.keywordPlus | LASER PHOTOCOAGULATION | - |
dc.subject.keywordPlus | PRETERM INFANTS | - |
dc.subject.keywordPlus | BIRTH | - |
dc.subject.keywordPlus | SEVERITY | - |
dc.subject.keywordPlus | EFFICACY | - |
dc.subject.keywordPlus | OUTCOMES | - |
dc.identifier.url | https://www.nature.com/articles/s41598-021-80989-z | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
222, Wangsimni-ro, Seongdong-gu, Seoul, 04763, Korea+82-2-2220-1365
COPYRIGHT © 2021 HANYANG UNIVERSITY.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.